Paper Title
A CLINICAL STUDY ON WAJA-UL-MUFASIL (RHEUMATOID ARTHRITIS) AND ITS MANAGEMENT IN UNANI MEDICINE
Article Identifiers
Authors
Dr.SHEEMA MARIYAM , Dr.N.Narasimha , Dr. Mohammed Ahsan Faroqui , Dr. Shaheen
Keywords
Key word: Waja-ul-Mufasil (Rheumatoid Arthritis), Autoimmune disease, Unani medicines, Humours, Mushil balgham o sauda (Purgative), Mohalil e auram (Resolvent), Musaffi khoon (Blood purifier), Musakkin Alam (Analgesic), Muqavvi Aasab (Nervine tonic).
Abstract
A CLINICAL STUDY ON WAJA-UL-MUFASIL(RHEUMATOID ARTHRITIS) AND ITS MANAGEMENT IN UNANI MEDICINE *Dr..Sheema Mariyam **Dr..N.Narasimha MD (Professor) ***Dr.. Mohammed Ahsan Faroqui, HOD PG.dept. of Moalejat. Govt. Niazmia Tibbi College Charminar, Hyd. ABSTRACT: Introduction: Rheumatoid arthritis (RA) is a long-standing inflammatory condition of undetermined causative factors with the hallmark of symmetric joint involvement. It is an autoimmune disease in which the body's immune system of the patient innocently targets its own body tissues. It principally attacks the synovial membrane. The most prevalent inflammatory arthritic condition, Rheumatoid arthritis (RA) affects 0.5% to 1% of the global population. It affects 15% (180 million) of the population of India. In the classical Unani literature, waja-ul-mufasil (RA) occurs in various joints caused by derangement of the body’s natural humours i.e., dam (blood), balgham (phlegm), safra (bile), and sauda (black bile) with various explanations mentioned by great scholars in Unani literature.The onset of the disease is insidious, beginning with prodrome of fatigue, weakness, joint stiffness, vague arthralgias and myalgias followed by pain and swelling. The most common age of onset is between 30 and 50 years.The cause is multifactorial and genetic and environmental factors play a part. Female gender is more susceptible. AIMS & OBJECTIVES: To evaluate the safety and efficacy of unani drugs in cases of Waja-ul-Mufasil (Rheumatoid Arthritis) and to prevent the long term side effects of DMARD’S, NSAID’S and CORTICOSTEROIDS. Methodology: The study of Waja-ul-Mufasil (Rheumatoid Arthritis) and its management with unani medicine was carried out in OPD of Govt. Nizamia General Hospital, Charminar, Hyderabad. It is A Single blind clinical trial to evaluate the safety and efficacy of Waja-ul -Mufasil (Rheumatoid Arthritis) with polyherbal unani formulation. Sample size of RA is 40 patients of either sex 18-50 years were taken. In this study patients were given polyherbal unani formulation for the total duration of treatment of 51 days i.e., orally in the form of decoction for 21 days based on formulations of unani Drugs having properties like Mushil balgham o sauda (Purgative), Mohalil e auram (Resolvent). After the period of 21 days of decoction, patients were given unani medicine possessing the properties of Musaffi khoon (Blood purifier), Musakkin Alam (Analgesic), Muqavvi Aasab (Nervine tonic) for next 30 days. Results and Conclusion: The study revealed that the drug showed extreme statistical significance P value <0.0001 in subjective parameters like Pain, Tenderness, Swelling, Morning stiffness, and Any deformity. The objective parameters like RA factor, ESR also showed the significant difference P value <0.0001. No adverse effect or toxicity was observed during clinical trial.
Downloads
How To Cite (APA)
Dr.SHEEMA MARIYAM, Dr.N.Narasimha , Dr. Mohammed Ahsan Faroqui, & Dr. Shaheen (March-2024). A CLINICAL STUDY ON WAJA-UL-MUFASIL (RHEUMATOID ARTHRITIS) AND ITS MANAGEMENT IN UNANI MEDICINE. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(3), c504-c529. https://ijnrd.org/papers/IJNRD2403267.pdf
Issue
Volume 9 Issue 3, March-2024
Pages : c504-c529
Other Publication Details
Paper Reg. ID: IJNRD_214678
Published Paper Id: IJNRD2403267
Downloads: 000122003
Research Area: Medical Science
Country: Hyderabad, Telangana, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2403267.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2403267
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
